We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HSY:NYSEThe Hershey Company Analysis

Data as of 2026-05-27 - not real-time

$198.76

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The Hershey Company is trading at $198.76, comfortably above its 20‑day ($189.40) and 50‑day ($197.53) SMAs and just shy of the $200 resistance level, while the 14‑day RSI sits at a neutral 57.5. A bullish MACD histogram (+1.52) and a positive MACD signal reinforce short‑term upside momentum, yet volume is on a declining trend, suggesting waning buying pressure. Valuation metrics signal caution: the trailing PE of 37x is well above the sector average and the DCF‑derived fair value of $129.65 implies the stock is currently overvalued, with an upside/downside estimate of only +8.5% relative to intrinsic value.
Fundamentally, Hershey posted solid top‑line growth of 10.6% YoY, supported by strong performance in core and premium chocolate brands, and maintains a healthy operating margin of 21.3% and ROE of 23.2%. However, the dividend payout ratio exceeds 100% (≈103.6%), raising questions about dividend sustainability despite a 3.04% yield. The company’s beta is exceptionally low (~0.03‑0.07), indicating minimal market‑wide price swings, but a 30‑day volatility of 27% and a max drawdown near 23% point to notable price swings on a stock‑specific basis. Overall, Hershey’s defensive consumer‑staple positioning tempers risk, but the combination of high valuation, elevated volatility, and dividend sustainability concerns suggest a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near $200 resistance with limited upside
  • declining volume despite bullish MACD
  • current overvaluation relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • steady revenue growth of 10.6% YoY
  • strong brand portfolio and premium chocolate expansion
  • high PE and forward PE indicating valuation premium

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • defensive consumer‑staple sector with durable moat
  • questionable dividend sustainability (payout >100%)
  • low beta but elevated stock‑specific volatility

Key Metrics & Analysis

Financial Health

Revenue Growth10.60%
Profit Margin9.13%
P/E Ratio37.0
ROE23.23%
ROA7.84%
Debt/Equity120.01
P/B Ratio8.5
Op. Cash Flow$2.3B
Free Cash Flow$1.5B

Technical Analysis

TrendNeutral
RSI57.5
Support$180.18
Resistance$200.00
MA 20$189.40
MA 50$197.53
MA 200$193.69
MACDBullish
VolumeDecreasing
Fear & Greed Index91.93

Valuation

Fair Value$129.65
Target Price$215.74
Upside/Downside8.55%
GradeOvervalued
TypeGrowth
Dividend Yield3.04%

Risk Assessment

Beta0.02
Volatility27.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.